The Most Popular Methods of Pre-Roll Infusion

Infused pre-rolls have become the most important growth segment within the industry's most popular product category.

According to the 2026 State of the Pre-Roll Market Report, infused pre-roll products generated $1.68 billion in sales during 2025, accounting for 47% of all pre-roll revenue while growing faster than any other segment within the category. Unit sales increased 27.8% year-over-year, continuing a trend that has seen infused products steadily gain share within the broader category, surpassing hybrid pre-rolls as the top revenue driver entering 2024.

Despite the segment's importance to brands producing pre-rolls in a competitive market, much of the industry conversation around infused pre-rolls looks at them as a single product type, but a more granular look tells a larger story.

Today's infused market includes pre-rolls featuring many forms of cannabis concentrates, including THCA diamonds, liquid diamonds, live resin, rosin, hash, kief, distillate, oil-based extracts and multi-infusion products that combine two or more concentrate types in a single infused pre-roll.

To better understand which methods are actually resonating with consumers and driving sales so far in 2026, we analyzed 2,772 infused pre-roll products - looking at the top 200 grossing infused pre-roll products from 15 state markets using sales analytics from cannabis data-firm Headset (following deduplication) - representing $419.6 million in total sales and 31.9 million units sold.

These products were categorized by infusion method and separated into single and multi-pack formats to identify which infusion methods generate the most revenue and sell the most units.

Some infusion methods move enormous volume but garner relatively low revenue, while other formats command premium pricing on lower unit sales. So let's take a look at the most popular methods of pre-roll infusion, which methods of pre-roll infusion generate the most revenue and which infused pre-rolls consumers can't get enough of.

A Look at Infused Pre-Rolls on the Market Today

Among the top selling 2,772 infused pre-rolls from January to mid-June 2026, 1,041 products had confirmed methods of infusion directly in the product name - like Jeeter's Baby Jeeter - Pina Colada Rosin Infused Pre-Roll 5-Pack (2.5g) – while 1,379 infused products were categorized based on infusion methods stated in product descriptions, and a total of 352 products (12.7%) fell into a General Infusion classification, where the specific method of infusion was not readily identifiable.

Industry chatter among professionals often focuses on specific concentrate types and infusion technologies – like a hash rosin hash-hole of infused-flower pre-roll - but a significant portion of the market continues to operate under a broader "infused" label. So even as brands experiment with increasingly sophisticated infusion methods, many products are still being sold without heavily emphasizing the specific concentrate or infusion method used.

From a market perspective, this suggests the overall infused segment remains powerful regardless of marketing language around infusion method. And while specific infusion methods are increasingly important differentiators, the broader infused designation continues to carry substantial commercial weight among consumers regardless.

However, when we isolate products with identifiable infusion methods, several clear leaders emerge.

Top Infusion Methods by Revenue

Among the infused pre-roll products in this analysis, we were able to identify 45 distinct infusion labels, which were standardized into 22 buckets of similar infusions – for example Distillate and Cannabis Oil / Distillate Extract rolled up into the Distillate/Oil/Extract segment - and finally categorized into 8 broader infusion families.

Rather than competing as part of one undifferentiated infused segment, brands are now selling products around distinct infusion families, infusion techniques and product formats.

Here is a look at the top methods of infusion by revenue driven through the first half of 2026:

Several distinct and prominent infusion families have emerged within the infused pre-roll segment, each occupying a different position in the market to try and stand out and entice consumers.

Diamond-Based products generated $157.5 million in sales, making them the largest identifiable infusion family in the dataset accounting for 37.5% of all revenues. These infused products also moved nearly 9.4 million units (29.5%) – the top performing group by both sales & unit sales – demonstrating a combination of scale and volume that other infusion families weren't able to match.

Multi-Infusion products ranked second and generated more than $82.7 million in sales (19.7%) across 411 products, while Rosin-Based, Kief-Dominant and Hash-Based products each occupy smaller but distinct positions within the market for consumers who prefer a specific, and often familiar type of infused pre-roll.

Live Resin-Based products ranked third among infusion families, generating approximately $65.2 million in sales on 3.7 million units. While only around 41% of the size of the leading Diamond-Based family, Live Resin-Based infused products continue to represent one of the largest infusion families in the market and remain a major driver of infused pre-roll sales.

Beyond these three major forms of infusion, Distillate and Oil-Based products generated $45.8 million in sales, but their importance becomes much clearer when pre-roll unit sales are considered. With 7.24 million units sold, the family moved around 75% as many units as Diamond-Based products despite generating less than half the revenue. This suggests that Distillate and Oil-Based products continue to play a significant role within the market's value-oriented infused segment.

General Infused products accounted for approximately $41.2 million in sales and 3.76 million units, and while these products were not assigned to a specific infusion method, they remain key to the segment and reinforce the fact that infused pre-rolls continue to generate significant consumer demand across a wide range of product types.

Taken together, the data points to an increasingly segmented infused pre-roll market. Rather than a single infusion method emerging as the dominant industry standard, multiple infusion families and formats are generating meaningful sales, volume and pricing power simultaneously. The result is a segment that is becoming more diverse, more specialized and increasingly defined by unique and competing infusion strategies.

This diversification of products becomes even more clear when we look beyond infusion families and examine the individual methods driving performance within those larger groups.

Although Diamond-Based products dominate at the infusion family level, the family's performance is not driven by a single infused product type. THCA/Diamond infused products generated $91.9 million in sales on 5.26 million units, making them the top individual method of infusion in the dataset, while Liquid Diamonds added another $31.8 million. And combined with smaller diamond-based infusion variations, the family has become the largest force within infused pre-rolls with 157.5 million in revenue.

The same pattern appears within the Live Resin-Based family. While standalone Live Resin products generated approximately $15.2 million in sales, Live Resin + Kief products generated more than three times that amount, producing $48 million in sales revenue. Independently, those methods tell one story, but viewed together, they bring to light the true scale of the Live Resin-Based family.

The distinction matters as individual methods of infusion often fluctuate as brands experiment with new concentrates, formats and marketing strategies. Infusion families, however, provide a clearer picture of how the broader market is evolving. And increasingly, one of the most important developments in this evolution is the rise of infused pre-rolls produced around multiple concentrates and methods rather than a single infusion concentrate and/or method.

Multiple Methods of Infusion on the Rise

One of the more interesting trends revealed in this analysis is the growing success and quantity of products built around multiple methods of infusion, where historically, infused pre-rolls were often differentiated by a single concentrate and infusion method.

Traditionally, an infused product would be marketed as a distillate-infused pre-roll, a live resin pre-roll or a hash-infused pre-roll, and while these products continue to play an important role within the category, some of the strongest-performing products in today's market combine multiple concentrate types within a single product offering.

The family analysis assigns each product to one primary infusion family. The following analysis is broader and includes every identified method containing multiple infusion components, including methods assigned to Diamond-Based and Live Resin-Based families.

Infused Pre-Roll Sales Featuring Multiple Infusion Methods

Live Resin + Kief products generated approximately $48 million in sales, making them one of the largest and most familiar infusions in the dataset. Quad Infused products followed with $38.0 million, while Distillate/Oil + Kief products generated another $32.2 million in sales. Liquid Diamonds + Kief produced $9.0 million, THCA Diamonds + Kief drove $7.2 million and THCA/Diamonds + Crumble infused pre-rolls contributed $4.6 million.

Collectively, these 9 multi-infusion methods generated more than $143.5 million in sales and represent some of the most productive and widely recognizable infusion methods in the market.

To understand which methods generate the most sales relative to the number of products on the market, the following table looks at average revenue per product by specific infusion method, which is calculated by dividing each infusion method's total sales by the number of products assigned to that method.

A higher number means fewer products are doing more of the work, which is a strong signal of consumer demand concentration around specific infusion methods.

Revenue Per Product by Infusion Method

Liquid Diamonds + Kief products generated the highest revenue-per-product at around $561k, followed by Liquid Diamonds + THCA/Frost at around $326K and Quad Infused products at around $297,000. Live Resin + Kief also performed strongly at roughly $254k per product. Several standalone and combination Diamond-Based methods also generated exceptionally strong revenue relative to the number of products represented by each method.

This shift toward multi-concentrate formats is one of the most important developments occurring within the infused segment today. Rather than relying on a single concentrate type as the primary selling point, many brands are increasingly developing products around combinations of concentrates and methods of infusion that create entirely new product formats.

THCA Diamonds emerged as the largest individual infusion method on the market by revenue, generating $91.9 million in total sales, Live Resin + Kief ranked second with $48.0 million, followed by General Infusion at $41.2 million and Quad Infused products at $38.0 million. Several additional standalone infusion methods continue to generate substantial sales, but some of the segment's strongest-performing infused products are increasingly being built around a combination of concentrates rather than a single infusion source.

The most important question for brands within the infused pre-roll segment to ask may no longer be which concentrate or method performs the best, but which combination of concentrates generates the strongest reactions from consumers.

Comparing Revenue Leaders and Volume Leaders

As we've seen, not all infused methods succeed in the same way, with some generating large amounts of revenue while others build their revenues on high unit sales.

Top Infusion Methods by Revenue & Unit Sales

THCA Diamonds emerged as the largest individual infusion method by revenue, generating $91.9 million in total infused pre-roll sales, while Live Resin + Kief pre-rolls ranked second, bringing in $48 million, followed by General Infused products at $41.2 million and Quad Infused products at $38 million in revenue.

Unit sales tell us a nuanced story, with THCA/Diamonds leading both revenue and volume, while several lower-priced methods also ranked among the market’s largest unit-sales drivers.

THCA/Diamond products generated more unit sales (5.26 million) than any other method in our dataset, narrowly ahead of Distillate/Oil/Extract at 5.11 million units. General Infusion ranked third with 3.76 million units. The average unit price, however, gives us strong insights into consumer buying behaviors and why these categories rank where they do on sales revenue and unit sales charts.

Distillate/Oil/Extract infused pre-roll products averaged $6.28 per item, making them one of the lowest-priced major infusion method in the dataset compared to Quad Infused products averaged $27.88, while Rosin and Live Resin products both exceeded $23.50 per item.

Infused Segment Pre-Roll Sales by Average Price

This has created three distinct competitive positions within the market.

The first – and most favorable - consists of methods that generate both strong revenue and strong volume. THCA Diamonds are the clearest example, producing substantial sales, ranking first in both revenue and total unit sales.

The second consists of methods that are primarily volume-driven, with Distillate/Oil/Extract pre-roll products fitting the profile. While they generate less revenue than premium concentrate categories, they consistently move enormous amounts of product, remaining one of the infused segment's most important volume engines.

And finally, the third consists of premium infusion methods and formats that generate revenue through higher price points rather than sheer volume alone, with Rosin/Solventless, Live Resin and Quad Infused products falling into this category. Their unit sales may trail those of more accessible infusion methods, but their higher average prices allow them to generate meaningful revenue on fewer units sold.

In short, there is no single path to success within the infused segment. Different methods occupy different economic positions within the market, allowing multiple infusion strategies to coexist in parallel to meet varying preferences by infused pre-roll consumers.

Comparing Infused Revenue & Volume Sales Leaders

While THCA/Diamonds dominate revenue, Distillate/Oil/Extract products rank second in unit sales volume despite ranking sixth by revenue. Infusions leveraging Quad Infused formats, Rosin / Solventless and standalone Live Resin generate some of the highest average prices in the market despite controlling smaller shares of overall sales volume. So rather than converging around a single infusion strategy, the infused segment can clearly support multiple successful infused product lines simultaneously.

Infused Multi-Packs are Reshaping the Segment

Infused pre-roll multi-pack products generated $262.8 million in sales, accounting for nearly two-thirds of all infused revenue represented in our dataset, meanwhile single pre-roll units amassed $156.8 million in sales though they accounted for the majority of units sold.

Comparing Multi-Pack to Single Pre-Roll

This breakdown closely mirrors broader pre-roll category trends where multi-packs have continually increased their share of pre-roll sales over the past several years.

However, the most important finding is not simply that multi-packs drive sales, it's that certain infusion methods appear to benefit from multi-pack formats more than others.

Method of Infusion Performance by Pack Size

Quad Infused products derive the overwhelming majority of their revenue from multi-pack sales at 97.1% of revenues, while THCA/Diamonds + Solventless Hash/Rosin and Liquid Diamonds + Kief products demonstrated a similar pattern at 96.7% and 88.8% respectively. By contrast, THCA Diamonds perform exceptionally well across both multi-packs ($63.9M) and singles ($28M), generating revenue across both volume shoppers and single-serving splurgers.

Distillate and Oil-Based infusion methods generate substantial single-unit sales volume, reinforcing their position as one of the segment's most important value-oriented infused offerings. While some methods of infusion appear to be optimized for premium multi-pack positioning, others remain dependent on lower-priced single formats, with a select group appearing capable of performing successfully in both.

What the Future Holds for Infused Pre-Rolls

Rather than converging around a single infusion method, the market clearly supports a growing number of successful approaches and formats to infused pre-rolls. Diamond-Based infused pre-rolls have emerged as the largest infusion family, accounting for 37.5% of sales and 29.5% of units, while THCA/Diamonds currently lead all individual infusion methods in both revenue and unit sales. Multi-Infusion products now rank as the second-largest family with $82.7 million in sales, while Live Resin-Based family continues to represent a major share of the infused pre-roll market ($65.2M). The Distillate and Oil-Based family remains one of the infused segment's most important sources of unit sales volume.

Distillate and Oil-Based products remain one of the category’s most important volume engines, generating 7.24 million units despite a comparatively low average price. The Multi-Infusion family includes methods such as Jeeter's Quad Infused pre-rolls that are generating some of the strongest revenue metrics in the pre-roll market, suggesting the complex product architecture may become increasingly important in attracting consumers as the segment evolves. The Rosin-Based, Hash-Based and Kief-Dominant families control smaller shares of the markets but have clearly defined positions within the segment, showing that different infusion families can still capture meaningful market share.

Pre-rolls featuring multiple infusion methods are generating substantial sales with many at a premium price point, particularly Quad Infused product, but the most important takeaway from this analysis is that the data shows no single infusion family has established overwhelming dominance – though Diamond-Based products are certainly making their case.

This results in a product segment that is becoming more sophisticated and niche by the day, increasingly being defined by competing approaches to infusion rather than a single industry standard.

For manufacturers, brands and retailers, understanding how those infusion strategies perform relative to one another may become one of the most important competitive advantages as infused pre-rolls continue to expand their role within the broader cannabis market.

And for help dialing in your infused pre-roll line, including the automated infusion machinery that gets the job done and custom branded pre-rolled cones, tubes and blunts, reach out to the Pre-Roll Experts at Custom Cones USA today.